Safety Alerts & Recalls
Search all Safety Alerts & Recalls
Latest Alerts
Recall on All ETHEX Brand Disopyramide Extended Release 150 mg Capsules
The ETHEX Corporation, a subsidiary of KV Pharmaceutical, has recalled ALL lots of ETHEX brand disopyramide phosphate extended release 150mg capsules. These recalled capsules may have been manufactured under conditions that did not meet the current manufacturing standards called Good Manufacturing Practices (cGMPs). Some ETHEX products have recently had specific lots recalled due to defects found, including oversized tablets. ETHEX is now recalling all of their products to ensure that no other defective products remain available to patients.
The ETHEX capsules and the NDC number involved in the recall are listed below. The NDC number is a product number that is sometimes listed on a prescription label.
Disopyramide Phosphate ER Capsules, 150mg (NDC 58177-002-04)
For more information, please visit:
http://www.ethex.com/news/pressRelease012809.aspx
Learn More
Recall on All ETHEX Brand Doxazosin Tablets
The ETHEX Corporation, a subsidiary of KV Pharmaceutical, has recalled ALL lots of ETHEX brand doxazosin mesylate tablets. These recalled tablets may have been manufactured under conditions that did not meet the current manufacturing standards called Good Manufacturing Practices (cGMPs). Some ETHEX products have recently had specific lots recalled due to defects found, including oversized tablets. ETHEX is now recalling all of their products to ensure that no other defective products remain available to patients.
The ETHEX tablets and their NDC numbers involved in the recall are listed below. The NDC number is a product number that is sometimes listed on a prescription label.
Doxazosin Mesylate Tablets, 1mg (NDC 58177-266-04 & NDC 58177-266-08)
Doxazosin Mesylate Tablets, 2mg (NDC 58177-267-04 & NDC 58177-267-08)
Doxazosin Mesylate Tablets, 4mg (NDC 58177-268-04 & NDC 58177-268-08)
Doxazosin Mesylate Tablets, 8mg (NDC 58177-269-04 & NDC 58177-269-08)
For more information, please visit:
http://www.ethex.com/news/pressRelease012809.aspx
Learn More